SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-009028
Filing Date
2020-05-15
Accepted
2020-05-15 14:11:37
Documents
49
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 372154
2 ex31-1.htm EX-31.1 17144
3 ex31-2.htm EX-31.2 17138
4 ex32-1.htm EX-32.1 6314
  Complete submission text file 0001493152-20-009028.txt   2301028

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE vicp-20200331.xml EX-101.INS 304742
6 XBRL SCHEMA FILE vicp-20200331.xsd EX-101.SCH 28393
7 XBRL CALCULATION FILE vicp-20200331_cal.xml EX-101.CAL 37578
8 XBRL DEFINITION FILE vicp-20200331_def.xml EX-101.DEF 110154
9 XBRL LABEL FILE vicp-20200331_lab.xml EX-101.LAB 204830
10 XBRL PRESENTATION FILE vicp-20200331_pre.xml EX-101.PRE 170474
Mailing Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041
Business Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041 470-514-4013
Vicapsys Life Sciences, Inc. (Filer) CIK: 0001468639 (see all company filings)

IRS No.: 621153426 | State of Incorp.: FL
Type: 10-Q | Act: 34 | File No.: 000-56145 | Film No.: 20883765
SIC: 2834 Pharmaceutical Preparations